Brincidofovir

Records for this ingredient, by country (identity only).

ATC J05AB17 · 2 markets · 4 records

Brincidofovir 2 markets · 4 records Forms

Filters

MarketUS 2 CA 2

Strength

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

100 mgtabletTembexa also in CA
10 mg per mL / per unit basis not statedliquidTembexa

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

100 mgtabletTembexa also in US
10 mg per mL / per unit basis not statedliquidTembexa

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	CA
100 mg tablet	Tembexa	Tembexa
10 mg per mL / per unit basis not stated cannot compare liquid	Tembexa	Tembexa

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.